vs
Absci Corp（ABSI）与ICON PLC（ICLR）财务数据对比。点击上方公司名可切换其他公司
ICON PLC的季度营收约是Absci Corp的3142.8倍（$2.0B vs $650.0K）。ICON PLC净利率更高（0.1% vs -4548.0%，领先4548.1%）。ICON PLC同比增速更快（0.6% vs -2.3%）。ICON PLC自由现金流更多（$333.9M vs $-29.3M）。过去两年ICON PLC的营收复合增速更高（0.6% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
ICON plc是总部位于爱尔兰的跨国医疗智能与临床研究服务机构，专注为全球医药健康领域客户提供专业研究及情报支持，截至2025年2月，已在全球55个国家布局业务，员工规模约4.19万人。
ABSI vs ICLR — 直观对比
营收规模更大
ICLR
是对方的3142.8倍
$650.0K
营收增速更快
ICLR
高出2.9%
-2.3%
净利率更高
ICLR
高出4548.1%
-4548.0%
自由现金流更多
ICLR
多$363.2M
$-29.3M
两年增速更快
ICLR
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $2.0B |
| 净利润 | $-29.6M | $2.4M |
| 毛利率 | — | — |
| 营业利润率 | -4775.5% | 4.2% |
| 净利率 | -4548.0% | 0.1% |
| 营收同比 | -2.3% | 0.6% |
| 净利润同比 | -2.0% | -98.8% |
| 每股收益（稀释后） | $-0.19 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSIICLR
| Q4 25 | $650.0K | — | ||
| Q3 25 | $378.0K | $2.0B | ||
| Q2 25 | $593.0K | $2.0B | ||
| Q1 25 | $1.2M | $2.0B | ||
| Q4 24 | $665.0K | — | ||
| Q3 24 | $1.7M | $2.0B | ||
| Q2 24 | $1.3M | $2.1B | ||
| Q1 24 | $898.0K | $2.1B |
净利润ABSIICLR
| Q4 25 | $-29.6M | — | ||
| Q3 25 | $-28.7M | $2.4M | ||
| Q2 25 | $-30.6M | $183.0M | ||
| Q1 25 | $-26.3M | $154.2M | ||
| Q4 24 | $-29.0M | — | ||
| Q3 24 | $-27.4M | $197.1M | ||
| Q2 24 | $-24.8M | $146.9M | ||
| Q1 24 | $-22.0M | $187.4M |
营业利润率ABSIICLR
| Q4 25 | -4775.5% | — | ||
| Q3 25 | -7977.2% | 4.2% | ||
| Q2 25 | -5293.9% | 10.4% | ||
| Q1 25 | -2351.9% | 11.0% | ||
| Q4 24 | -4477.3% | — | ||
| Q3 24 | -1698.7% | 14.1% | ||
| Q2 24 | -2104.0% | 10.8% | ||
| Q1 24 | -2616.7% | 13.7% |
净利率ABSIICLR
| Q4 25 | -4548.0% | — | ||
| Q3 25 | -7594.2% | 0.1% | ||
| Q2 25 | -5155.0% | 9.1% | ||
| Q1 25 | -2234.6% | 7.7% | ||
| Q4 24 | -4358.3% | — | ||
| Q3 24 | -1610.7% | 9.7% | ||
| Q2 24 | -1948.8% | 6.9% | ||
| Q1 24 | -2447.1% | 9.0% |
每股收益（稀释后）ABSIICLR
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $-0.20 | $0.03 | ||
| Q2 25 | $-0.24 | $2.30 | ||
| Q1 25 | $-0.21 | $1.90 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.24 | $2.36 | ||
| Q2 24 | $-0.22 | $1.76 | ||
| Q1 24 | $-0.22 | $2.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $468.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $189.4M | $9.3B |
| 总资产 | $216.3M | $16.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABSIICLR
| Q4 25 | $144.3M | — | ||
| Q3 25 | $152.5M | $468.9M | ||
| Q2 25 | $38.0M | $390.4M | ||
| Q1 25 | $47.0M | $526.7M | ||
| Q4 24 | $112.4M | — | ||
| Q3 24 | $38.2M | $695.5M | ||
| Q2 24 | $42.9M | $506.6M | ||
| Q1 24 | $58.8M | $396.1M |
总债务ABSIICLR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABSIICLR
| Q4 25 | $189.4M | — | ||
| Q3 25 | $210.3M | $9.3B | ||
| Q2 25 | $173.4M | $9.6B | ||
| Q1 25 | $198.8M | $9.5B | ||
| Q4 24 | $179.1M | — | ||
| Q3 24 | $201.3M | $9.8B | ||
| Q2 24 | $221.5M | $9.6B | ||
| Q1 24 | $240.1M | $9.4B |
总资产ABSIICLR
| Q4 25 | $216.3M | — | ||
| Q3 25 | $245.0M | $16.5B | ||
| Q2 25 | $209.9M | $16.6B | ||
| Q1 25 | $232.4M | $16.7B | ||
| Q4 24 | $213.6M | — | ||
| Q3 24 | $235.2M | $17.2B | ||
| Q2 24 | $255.5M | $17.0B | ||
| Q1 24 | $274.9M | $17.0B |
负债/权益比ABSIICLR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $387.6M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $333.9M |
| 自由现金流率自由现金流/营收 | -4505.4% | 16.3% |
| 资本支出强度资本支出/营收 | 15.8% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 164.59× |
| 过去12个月自由现金流最近4个季度 | $-94.2M | $1.0B |
8季度趋势，按日历期对齐
经营现金流ABSIICLR
| Q4 25 | $-29.2M | — | ||
| Q3 25 | $-25.0M | $387.6M | ||
| Q2 25 | $-16.9M | $146.2M | ||
| Q1 25 | $-21.8M | $268.2M | ||
| Q4 24 | $-17.0M | — | ||
| Q3 24 | $-20.7M | $402.7M | ||
| Q2 24 | $-16.8M | $218.6M | ||
| Q1 24 | $-17.9M | $327.1M |
自由现金流ABSIICLR
| Q4 25 | $-29.3M | — | ||
| Q3 25 | $-26.0M | $333.9M | ||
| Q2 25 | $-17.1M | $113.9M | ||
| Q1 25 | $-21.9M | $239.3M | ||
| Q4 24 | $-17.0M | — | ||
| Q3 24 | $-20.8M | $359.3M | ||
| Q2 24 | $-17.2M | $182.3M | ||
| Q1 24 | — | $299.9M |
自由现金流率ABSIICLR
| Q4 25 | -4505.4% | — | ||
| Q3 25 | -6876.5% | 16.3% | ||
| Q2 25 | -2883.0% | 5.6% | ||
| Q1 25 | -1854.5% | 12.0% | ||
| Q4 24 | -2554.4% | — | ||
| Q3 24 | -1221.6% | 17.7% | ||
| Q2 24 | -1352.4% | 8.6% | ||
| Q1 24 | — | 14.3% |
资本支出强度ABSIICLR
| Q4 25 | 15.8% | — | ||
| Q3 25 | 254.5% | 2.6% | ||
| Q2 25 | 37.6% | 1.6% | ||
| Q1 25 | 2.1% | 1.4% | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.8% | 2.1% | ||
| Q2 24 | 26.2% | 1.7% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率ABSIICLR
| Q4 25 | — | — | ||
| Q3 25 | — | 164.59× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.04× | ||
| Q2 24 | — | 1.49× | ||
| Q1 24 | — | 1.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABSI
暂无分部数据
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
